| Fazia Weaver, NP | |
|
300 Pompton Rd, Wayne, NJ 07470-2103 | |
| (973) 720-2956 | |
| (973) 720-2632 |
| Full Name | Fazia Weaver |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 300 Pompton Rd, Wayne, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174828800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 26NJ00313200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fazia Weaver, NP 300 Pompton Rd, Wayne, NJ 07470-2103 Ph: (973) 720-5000 | Fazia Weaver, NP 300 Pompton Rd, Wayne, NJ 07470-2103 Ph: (973) 720-2956 |
News Archive
People with Alzheimer's disease who also have diabetes or high blood pressure may die sooner than people without such disorders, according to a study published in the November 4, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.
BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.
Misinformation and misunderstanding about the risks associated with ionizing radiation create heightened public concern and fear, and may result in avoidance of screening mammography that can detect early cancers.
ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.
› Verified 6 days ago
Cecilia Ezuduemoih, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1501 Hamburg Tpke, Wayne, NJ 07470 Phone: 862-684-8484 | |
Mrs. Deanna Marie Sanacore, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 342 Hamburg Tpke Ste 107, Wayne, NJ 07470 Phone: 973-870-0777 Fax: 888-465-2135 | |
Yelena Anfibio, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 506 Hamburg Tpke Ste 202, Wayne, NJ 07470 Phone: 973-595-1809 | |
Jacquelyn Marie Amodeo, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 246 Hamburg Tpke Ste 205, Wayne, NJ 07470 Phone: 973-389-1800 | |
Tangina B Rahman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15 Vizcaya Ct, Wayne, NJ 07470 Phone: 973-870-8744 | |
Se Young Oh, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1680 State Route 23 Ste 250, Wayne, NJ 07470 Phone: 973-633-1122 Fax: 973-832-7550 | |
Hamida 0 Yaqoobi, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2440 Hamburg Tpke, Wayne, NJ 07470 Phone: 973-839-3400 |